Dr. Shelby Nichole Fisher, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 137 N 7th St, Seward, NE 68434 Phone: 402-643-3909 |
Dr. Matthew Joseph Kunasek, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 306 S 4th St, Suite 100, Seward, NE 68434 Phone: 402-643-2931 Fax: 402-643-4258 |
Dr. Richard Alan Rolfsmeier, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1877 Karol Kay Blvd, Seward, NE 68434 Phone: 402-643-3820 |
Dr. Mark Alan Minchow, DDS Dentist Medicare: Medicare Enrolled Practice Location: 306 S 4th St, Suite 100, Seward, NE 68434 Phone: 402-643-2931 Fax: 402-643-4258 |
Dr. James Clinton Landholm, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 137 N 7th St, Seward, NE 68434 Phone: 402-643-3909 |
Dr. Steven Carl Kruse, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 111 N 3rd St, Seward, NE 68434 Phone: 402-643-2931 |
Dr. Andrew Thomas Hibbert, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 306 S 4th St, Suite 100, Seward, NE 68434 Phone: 402-643-2931 Fax: 402-643-4258 |
News Archive
Meda has acquired exclusive licensing rights to Nalox (treatment of fungal nail infections/nail psoriasis) from Moberg Derma AB.
StemCells, Inc. announced today that it has submitted a protocol to the FDA for initiation of a second clinical trial of its proprietary HuCNS-SC human neural stem cells in neuronal ceroid lipofuscinosis, which is also often referred to as Batten disease.
Watson Pharmaceuticals, Inc. has confirmed that it has filed two Abbreviated New Drug Applications (ANDAs) with the U.S. Food and Drug Administration seeking approval to market its guaifenesin extended-release 600mg and 1200mg tablets and its dextromethorphan HBr/guaifenesin extended-release 30mg/600mg and 60mg/1200mg tablets prior to the expiration of patents owned by Reckitt Benckiser Inc.
PENTAX Medical, a healthcare industry leader in endoscopic imaging, will release the next generation High Definition (HD+) EPK-i7000 video processor and i10 series endoscopes during the United European Gastroenterology week from October 20-24, 2012 in Amsterdam, The Netherlands.
Covidien, a leading global provider of healthcare products, today announced that the Solitaireā¢ FR Revascularization Device has been approved for investigational use in the Interventional Management of Stroke (IMS III) trial.
› Verified 7 days ago